Veradigm | MDRX - Le Coût Des Ventes





Le Coût Des Ventes Changement Date
Alcidion AUD 6.82M 1.16M 2025-12
Ambu A/S DKK 625M 14M 2026-03
Amplifon EUR -241.7M 701.87M 2025-12
Cardinal Health USD 58.54B 4.82B 2026-03
Centene USD 44.39B 3.2B 2026-03
Charles River Laboratories USD 716.51M 5.76M 2026-03
Cigna USD 62.41B 4.1B 2026-03
Coloplast 2.31B 110M 2025-12
Computer Programs Systems USD 52.17M 9.8M 2025-12
Convatec Group USD 515.3M 270.15M 2024-12
CVS Health USD 84.8B 7.32B 2026-03
Diasorin EUR 101M 7.58M 2026-03
Elevance Health USD 38.07B 75M 2025-12
General Electric Aerospace USD 8.15B 764M 2026-03
Gulf Medical Proj AED 151.05M 11.52M 2025-12
Humana USD 26.54B 1.15B 2025-03
IQVIA Holdings USD 3.08B 161M 2026-03
Laboratory Of America USD 2.6B 4.2M 2026-03
Maximus USD 984M 62.68M 2026-03
McKesson USD 92.25B 10.22B 2026-03
Med Life RON 283.78M 123.71M 2025-09
Molina Healthcare USD 9.77B 406M 2026-03
Omnicell USD 169.52M 14.14M 2026-03
Oriola-kd EUR 461.6M 35.5M 2025-12
Owens Minor USD 436.92M 32.62M 2025-12
Quest Diagnostics USD 1.99B 57M 2026-03
Rede D'or Sao Luiz BRL 11.12B 4.84B 2026-03
Siemens Healthineers EUR 3.54B 214M 2026-03
Sonova Holding CHF 539.4M 11.5M 2025-12
UnitedHealth USD 94.72B 2.2B 2025-12
Veeva Systems USD 220.92M 7.45M 2026-03
Veradigm USD 124.74M 56.25M 2022-12
Xerox USD 1.14B 104M 2025-06